Vesicular stomatitis virus (VSV) will be used to study regulation of macromolecular synthesis with particular emphasis on (1) the role of interference caused by defective interfering (DI) particles in vivo and on (2) the functional interactions of the viral glycoprotein G with antibody and with the host cell. These studies will relate to the possibility of using DI particles or DI-specific nucleic acid sequences to regulate viral infections. Studies on the glycoprotein will define functional domains and elucidate the basic mechanisms by which the host defends against viral infections and how viruses overcome these defenses. These studies also provide a novel way to examine human tumor antigens. The experimental approach with DI particles will be to initiate infections in mice with known quantities of DI particles and standard VSV. The detection of synthesis of DI particles will be by Northern blotting with DI-specific cloned 32P-DNA sequences and correlating the presence of DI RNA with the disease process. Naturally virulent New Jersey isolates of VSV will be examined for their ability to generate DI particles and mapped physically against laboratory strains to determine if virulence markers are associated with certain regions of the genome. G protein will be approached via monoclonal and anti-peptide antibodies. The parameters to be measured will be neutralization, precipitation of whole virions, precipitation of G protein, and antibody-induced degradation of G protein. Mechanisms of these interactions will be elucidated. Non-VSV proteins acquired by VSV during the budding-out process from HeLA cells will be characterized in respect to their phosphate and carbohydrate content and to their synthesis and association with tumorigenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI020896-05
Application #
3130689
Study Section
Virology Study Section (VR)
Project Start
1979-06-01
Project End
1989-05-31
Budget Start
1986-06-01
Budget End
1987-05-31
Support Year
5
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Plakhov, I V; Arlund, E E; Aoki, C et al. (1995) The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system. Virology 209:257-62
Fan, W; Chen, S S; Huang, A S (1989) Multiple thermolabile and temperature-sensitive lesions in mutant tl17 of vesicular stomatitis virus. Intervirology 30:148-55
Chen, S S; Huang, A S (1989) Human cervical carcinoma cell lines contain an antigen identical to the tumor-specific 75 kDa antigen of HeLa cells: detection by viral acquisition. J Virol Methods 24:159-67
Chen, S S; Ariel, N; Huang, A S (1988) Membrane anchors of vesicular stomatitis virus: characterization and incorporation into virions. J Virol 62:2552-6
Petrarca, M A; Reiss, C S; Diamond, D C et al. (1988) T cell hybridomas define the class II MHC-restricted response to vesicular stomatitis virus infection. Microb Pathog 5:319-32
Huang, A S; Boni, J (1987) Genetic engineering of antiviral agents. Antimicrob Agents Chemother 31:1293-5
Chen, S S; Doherty, R; O'Rourke, E J et al. (1987) Effects of transport inhibitors on the generation and transport of a soluble viral glycoprotein. Virology 160:482-4
Reiss, C S; Chen, S S; Huang, A S et al. (1986) VSV G protein induces murine cytolytic T lymphocytes. Microb Pathog 1:261-7
Huang, A S; Wu, T Y; Yilma, T et al. (1986) Characterization of virulent isolates of vesicular stomatitis virus in relation to interference by defective particles. Microb Pathog 1:205-15
Chen, S S; Huang, A S (1986) Further characterization of the vesicular stomatitis virus temperature-sensitive O45 mutant: intracellular conversion of the glycoprotein to a soluble form. J Virol 59:210-5

Showing the most recent 10 out of 11 publications